FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...

Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...

MISSISSAUGA, ON, Nov. 10, 2020 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test ...

BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...

The test is based on the company's BD Veritor Plus System, a handheld diagnostic device. The test is used in combination with the company's BD Veritor Plus System, a handheld electronic diagnostic ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently received the Emergency Use Authorization (EUA) from the FDA for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with ...

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October FRANKLIN LAKES, New Jersey, Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a ...